Pipeline Lundbeck to present new Vyepti and bocunebart data at EAN 2026 PharmaTimesLundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva.NeuroscienceRead full story pharminent June 24, 2026 (Last updated: June 24, 2026) PharmaTimes Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva. Neuroscience Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: URA and Lilly join forces to harmonise drug-wearable obesity careNext: SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy Related Stories Pipeline Gilead looks to upcoming inflammation, cancer catalysts as pressure to diversify mounts pharminent August 5, 2026 Pipeline Sanofi drops two more programmes in R&D clear-out pharminent July 30, 2026 Pipeline Lundbeck preps for key bexicaserin data around year-end pharminent July 20, 2026
